Cargando…
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
Lennox-Gastaut syndrome (LGS) is a severe, childhood-onset, developmental epileptic encephalopathy, with different etiologies and co-morbidities. Seizure treatment in LGS represents a major challenge; new antiepileptic drugs (AEDs) are developed to especially address seizures resulting in high morbi...
Autores principales: | Balagura, Ganna, Riva, Antonella, Marchese, Francesca, Verrotti, Alberto, Striano, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008198/ https://www.ncbi.nlm.nih.gov/pubmed/32103957 http://dx.doi.org/10.2147/NDT.S185774 |
Ejemplares similares
-
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide
por: McMurray, Rob, et al.
Publicado: (2016) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Stafstrom, Carl E
Publicado: (2009) -
Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy)
por: Kluger, Gerhard, et al.
Publicado: (2007) -
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
por: Gresham, Jessica, et al.
Publicado: (2010) -
The burden of illness in Lennox–Gastaut syndrome: a systematic literature review
por: Strzelczyk, Adam, et al.
Publicado: (2023)